Decker Robert J

JNJ VP Decker sells 4,075 shares at $247.87; retains 23,682 shares. Timing aligned with prior JNJ sales that preceded declines.

Decker sold 4,075 shares at $247.87 on 2026-02-27, reducing holdings by 14.7% to 23,682 shares, generating $1,010,070.25 in proceeds. The sale occurred near the 52-week high (within 0.7%), and his prior two sales at JNJ (2025-02-25 and 2024-08-30) were both well-timed at the 90-day mark, with post-sale returns of -7.8% and -5.8% respectively. His cross-ticker selling track record shows a 100.00% well-timed rate across 2 prior sales with an average 90-day return of -6.8%, indicating a consistent pattern of selling before subsequent declines. This transaction fits that established pattern: a sale at an elevated price point with a demonstrable history of JNJ sales preceding downward movement over the following 90 days. Investors tracking this insider's activity should note the repetition of the sell-before-decline pattern, now in its third occurrence at this ticker.

VP Corporate Controller Robert J Decker sells 6,999 JNJ shares at $165.88 for $1.2M, reducing holdings 25.0%.

Decker sold 6,999 shares at $165.88 on 2025-02-25, reducing his JNJ holdings from 28,000 to 21,001 shares, a 25.0% decrease in position size. His cross-ticker track record shows 1 prior sell with a 90-day well-timed rate of 100.00%, and his prior JNJ sale on 2024-08-30 was similarly well-timed (90d return -5.8%). The current stock price of $163.08 is now 2.6% below his transaction price and the sale occurred near the 52-week high of $167.38, positioning this sale favorably relative to recent price momentum (+6.7% over 30 days). While the consistent pattern of well-timed prior exits is noteworthy, a single VP-level sale in a mega-cap company with stable fundamentals ($22.5B quarterly revenue, +4.3% annual growth, $392.6B market cap) carries limited significance for broad investor interpretation.

VP Corporate Controller Robert J Decker sold 5,635 JNJ shares at $165.06 on 2024-08-30 for $930,113.10

Robert J Decker, VP Corporate Controller, sold 5,635 shares of Johnson & Johnson at $165.06 on 2024-08-30, reducing his holdings by 22.9% to 18,973 shares post-transaction. The sale occurred near the 52-week high of $167.16, and the stock has shown strong momentum with a 90-day gain of 14.5%. Johnson & Johnson trades at a P/E of 10.59 on a market cap of $402.4B, though the company has experienced annual revenue decline of 10.3% year-over-year with latest quarterly revenue of $22.4B and net income of $4.7B. The transaction's modest size relative to total market capitalization and the company's stable fundamentals suggest routine portfolio activity by a mid-level executive rather than a material signal about corporate performance or insider confidence.